Brief: Mithra Pharmaceuticals And Richter Sign Licence Agreement For Commercialisation Of Donesta®

Mithra Pharmaceuticals SA

15/02/2023 07:16

Feb 15 (Reuters) - Mithra Pharmaceuticals SA  MITRA.BR :
    * RICHTER AND MITHRA SIGN A LICENCE AGREEMENT FOR
COMMERCIALISATION OF DONESTA®, FIRST ESTETROL-BASED HORMONE
THERAPY
    * TERRITORIES COVERED BY AGREEMENT ARE GEOGRAPHICAL EUROPE,
CIS
COUNTRIES, LATIN AMERICA, AUSTRALIA AND NEW ZEALAND
    * UNDER TERMS OF LICENCE AGREEMENT, MITHRA IS ELIGIBLE TO
RECEIVE
EUR 55 MILLION IN UPFRONT PAYMENT
    * RICHTER WILL BE IN CHARGE OF SUPPLY AND PRODUCTION OF
PRODUCT
FOR ALL ITS TERRITORIES.

Source text for Eikon:  ID:nNDL8Zc70d 
Further company coverage:  MITRA.BR 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))